Systematic review / meta-analysis / 2022
Taurine supplementation reduced MDA and CRP levels in controlled trials, but did not significantly alter TNF-α or IL-6.
A systematic review and dose-response meta-analysis of controlled clinical trials evaluated the impact of taurine supplementation on inflammatory and oxidative stress biomarkers. Taurine significantly decreased levels of MDA (SMD = -1.17 µmol/l; 95% CI: -2.08, -0.26; P = 0.012) and CRP (SMD = -1.95 mg/l; 95% CI: -3.20, -0.71; P = 0.002). No significant effects were observed for TNF-α (SMD = -0.18 pg/ml; 95% CI: -0.56, 0.21; P = 0.368) or IL-6 (SMD = -0.49 pg/ml; 95% CI: -1.13, 0.16; P = 0.141). Time-response analysis showed a more pronounced alleviating effect at 56 days (8 weeks) after supplementation (P < 0.05).
- Study type
- Systematic review and dose-response meta-analysis of controlled trials
- Who was studied
- Participants in controlled clinical trials identified up to March 30, 2021
- What was measured
- Levels of malondialdehyde (MDA), C-reactive protein (CRP), TNF-α, and IL-6
THE PAPER
Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.
Faghfouri AH, Seyyed Shoura SM, Fathollahi P, Shadbad MA, Papi S, Ostadrahimi A, Faghfuri E. Eur J Clin Nutr, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.